JP2023516300A5 - - Google Patents
Info
- Publication number
- JP2023516300A5 JP2023516300A5 JP2022551637A JP2022551637A JP2023516300A5 JP 2023516300 A5 JP2023516300 A5 JP 2023516300A5 JP 2022551637 A JP2022551637 A JP 2022551637A JP 2022551637 A JP2022551637 A JP 2022551637A JP 2023516300 A5 JP2023516300 A5 JP 2023516300A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062983416P | 2020-02-28 | 2020-02-28 | |
| US62/983,416 | 2020-02-28 | ||
| US202063074841P | 2020-09-04 | 2020-09-04 | |
| US63/074,841 | 2020-09-04 | ||
| US202163144853P | 2021-02-02 | 2021-02-02 | |
| US63/144,853 | 2021-02-02 | ||
| PCT/US2021/019861 WO2021173964A1 (en) | 2020-02-28 | 2021-02-26 | Methods for activation and expansion of tumor infiltrating lymphocytes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023516300A JP2023516300A (ja) | 2023-04-19 |
| JPWO2021173964A5 JPWO2021173964A5 (https=) | 2024-01-26 |
| JP2023516300A5 true JP2023516300A5 (https=) | 2024-01-26 |
Family
ID=77491997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551637A Pending JP2023516300A (ja) | 2020-02-28 | 2021-02-26 | 腫瘍浸潤リンパ球の活性化及び増殖のための方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230108584A1 (https=) |
| EP (1) | EP4110352A4 (https=) |
| JP (1) | JP2023516300A (https=) |
| KR (1) | KR20230034198A (https=) |
| CN (1) | CN116096865A (https=) |
| AU (1) | AU2021228701A1 (https=) |
| CA (1) | CA3168932A1 (https=) |
| WO (1) | WO2021173964A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109536444B (zh) * | 2018-12-11 | 2022-06-28 | 吉林省拓华生物科技有限公司 | 一种适用于恶性实体瘤肿瘤浸润t淋巴细胞的分离诱导方法 |
| US12365871B2 (en) | 2020-04-28 | 2025-07-22 | Lyell Immunopharma, Inc. | Methods for culturing cells |
| CN114901805B (zh) | 2020-11-19 | 2023-07-25 | 苏州沙砾生物科技有限公司 | 肿瘤浸润淋巴细胞的培养方法及其用途 |
| AU2022227686A1 (en) | 2021-02-25 | 2023-07-27 | Lyell Immunopharma, Inc. | Ror1 targeting chimeric antigen receptor |
| US20240197873A1 (en) * | 2021-04-23 | 2024-06-20 | Suzhou Grit Biotechnology Co., Ltd. | Modified tumor-infiltrating lymphocyte and use thereof |
| AU2022409848A1 (en) * | 2021-12-17 | 2024-07-04 | Instil Bio, Inc. | Processing of tumor infiltrating lymphocytes |
| CN118414422A (zh) * | 2021-12-30 | 2024-07-30 | 苏州沙砾生物科技有限公司 | 一种修饰的肿瘤浸润淋巴细胞及其用途 |
| EP4471128A4 (en) * | 2022-01-29 | 2026-03-04 | Suzhou Grit Biotechnology Co Ltd | Modified tumor infiltrating lymphocyte and use thereof |
| WO2024020531A1 (en) * | 2022-07-21 | 2024-01-25 | Tract Therapeutics, Inc. | Immune cell expansion and uses thereof |
| WO2024215414A1 (en) * | 2023-04-12 | 2024-10-17 | Beam Therapeutics Inc. | Modified immune effector cells with improved efficacy |
| CN117417894A (zh) * | 2023-09-15 | 2024-01-19 | 毕诺济(上海)生物技术有限公司 | 敲除Roquin-1和/或Regnase-1基因的肿瘤浸润淋巴细胞及其应用 |
| WO2025092690A1 (zh) * | 2023-10-30 | 2025-05-08 | 苏州沙砾生物科技有限公司 | 一种修饰的细胞及其用途 |
| WO2025096638A2 (en) * | 2023-10-30 | 2025-05-08 | Turnstone Biologics Corp. | Genetically modified tumor infilitrating lymphocytes and methods of producing and using the same |
| WO2025106513A1 (en) * | 2023-11-13 | 2025-05-22 | KSQ Therapeutics, Inc. | Methods for producing edited tumor infiltrating lymphocytes |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2711418B1 (en) * | 2012-09-25 | 2017-08-23 | Miltenyi Biotec GmbH | Method for polyclonal stimulation of T cells by flexible nanomatrices |
| RU2671897C2 (ru) * | 2013-03-01 | 2018-11-07 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез | Способы получения из опухоли обогащенных популяций реактивных в отношении опухоли т-клеток |
| WO2015157636A1 (en) * | 2014-04-10 | 2015-10-15 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy |
| JP7057748B2 (ja) * | 2015-07-16 | 2022-04-20 | イェダ リサーチ アンド ディベロップメント カンパニー リミテッド | 遺伝子改変された抗第三者中枢性メモリーｔ細胞および免疫療法におけるその使用 |
| EP3364969A4 (en) * | 2015-10-20 | 2019-07-10 | Kite Pharma, Inc. | METHOD FOR THE PRODUCTION OF T CELLS FOR T CELL THERAPY |
| BR112019013940A2 (pt) * | 2017-01-06 | 2020-02-11 | Iovance Biotherapeutics, Inc. | Método de tratar um câncer com uma população de linfócitos infiltrantes de tumor, processo para preparação de uma população de linfócitos infiltrantes de tumor, população de linfócitos infiltrantes de tumor, e, composição farmacêutica. |
| US20200224161A1 (en) * | 2017-05-10 | 2020-07-16 | Iovance Biotherapeutics, Inc. | Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof |
| EP4501408A3 (en) * | 2017-11-17 | 2025-04-09 | Iovance Biotherapeutics, Inc. | Til expansion from fine needle aspirates and small biopsies |
| US20190284553A1 (en) * | 2018-03-15 | 2019-09-19 | KSQ Therapeutics, Inc. | Gene-regulating compositions and methods for improved immunotherapy |
-
2021
- 2021-02-26 EP EP21760177.2A patent/EP4110352A4/en active Pending
- 2021-02-26 WO PCT/US2021/019861 patent/WO2021173964A1/en not_active Ceased
- 2021-02-26 CN CN202180031516.0A patent/CN116096865A/zh active Pending
- 2021-02-26 CA CA3168932A patent/CA3168932A1/en active Pending
- 2021-02-26 US US17/802,080 patent/US20230108584A1/en active Pending
- 2021-02-26 KR KR1020227030600A patent/KR20230034198A/ko active Pending
- 2021-02-26 AU AU2021228701A patent/AU2021228701A1/en active Pending
- 2021-02-26 JP JP2022551637A patent/JP2023516300A/ja active Pending